Pancreatic Ductal Adenocarcinoma Derived From an Intraductal Papillary Neoplasm With Synchronous Incidental Glucagonoma: A Case Report and Literature Review

Pancreas. 2019 Apr;48(4):e24-e26. doi: 10.1097/MPA.0000000000001282.

Authors

Chiara Cornacchia¹, Mariangela Rutigliani, Alberto Serventi, Enrico Ciferri, Giulio Angelini, Marco Filauro

Affiliation

¹ Department of Surgery Galliera Hospital Genova, Italy cornacchia.chiara@gmail.com Department of Pathology Galliera Hospital Genova, Italy Department of Surgery Monsignor Galliano Hospital Acqui Terme (AL), Italy Department of Surgery Galliera Hospital Genova, Italy.

PMID: 30973467
DOI: 10.1097/MPA.0000000000001282

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Antimetabolites, Antineoplastic / therapeutic use
Carcinoma, Pancreatic Ductal / therapy*
Chemotherapy, Adjuvant
Deoxycytidine / analogs & derivatives
Deoxycytidine / therapeutic use
Gemcitabine
Glucagonoma / diagnosis
Glucagonoma / therapy*
Humans
Incidental Findings*
Male
Middle Aged
Pancreas / drug effects
Pancreas / pathology
Pancreas / surgery
Pancreatectomy
Pancreatic Neoplasms / therapy*
Splenectomy
Treatment Outcome

Substances

Antimetabolites, Antineoplastic
Deoxycytidine
Gemcitabine